Tim Mills, Managing Partner of ACF Investors, about the ups and downs of angel investing and the important role that angels continue to play in backing and nuturing exciting young businesses.

Quin AI, a predictive AI startup founded by two sisters, Gonca Gulser and Gulsah Gulser, has raised £582K funding led by SFC Capital and with participation from NCA, Logo Ventures, and StartersHub. The fund has been raised to scale Quin AI’s activities in the United Kingdom and Germany, as well as further innovations in AI for creating intelligent applications.

Bluezone, an insurtech reinventing life insurance for people with chronic illnesses has announced a £1.5m seed round led by Insurtech Gateway and AV8 Ventures. Oxford Capital, Portfolio Ventures and impactful angel investors including former CEO of AXA, Chief Transformation Officer Aegon Group, former Chairman of NHS England and a leading Fintech angel also participated in the round.

Oliver Woolley of Envestors makes the case for becoming an angel investor and why now is a good time to jump into the pool.

Data suggests Brits are resigning at the highest rate since 2009; it’s been dubbed ‘The Great Resignation’

Panthera Biosciences (Panthera) has secured £10 million of investment from BGF and Gresham House Ventures.

MitoRx Therapeutics secures investment from Science Angel Syndicate to develop its first-in-class therapeutics that target dysfunctional sulfide-signalling in mitochondria to halt the progress of degenerative diseases.

Science Angel Syndicate (SAS) was launched in September 2021 to supportinvestments into frontier scientific discoveries that impact society on a global scale. Leveraging their unique due diligence capabilities they have supported SAS investors to make an investment into MitoRx Therapeutics. 

Science Angel Syndicate co-founders, Dr Ben Miles and Dr Johnathan Matlock will be joining the Advisory Board of Elbow Beach Capital as part of a collaboration agreement.

SFC Capital is calling for urgent action to reinvigorate seed-stage investment and help secure the next generation of innovative businesses emerging across the UK, with SEIS at risk of becoming redundant as a funding mechanism due to startups’ growing funding needs and the impact of inflation.

Fearless Adventures invests in D2C (direct to consumer) startups, and its co-founder is David Newns. David sold two companies he founded for more than £150m, and is passionate about supporting new founders with the proceeds of those sales through his angel investments. 

Employee benefits platform Juno has raised $4m to transform outdated ‘work perks’ schemes by empowering employees to choose benefits that work for them. The round was led by Hoxton Ventures and joined by angels including Juno early adopters Tony Jamous, CEO of OysterHR and Christian Owens, CEO of Paddle. Other angel investors include the CEOs of Learnerbly, Captify, Jungle Creations, SuperAwesome and Heights.

52 North Health, a UK and US-based med-tech start-up, has raised £1 million in its first round of funding from leading UK and European specialist investors. The round was led by Cambridge Enterprise, the commercialisation arm of the University of Cambridge, with participation from Crista Galli Ventures, King’s Health Partners MedTech Innovations, Meltwind, Milltrust Ventures and a number of angels.

Gannon's Catherine Ramsay asks "what are the key issues and pitfalls encountered where a company is reorganising and it has subsisting enterprise management incentive (EMI) options?"